HealthDay - FRIDAY, April 29 (HealthDay News) -- Zytiga (abiraterone acetate), used in combination with the steroid prednisone, has been approved to treat advanced prostate cancer, the U.S. Food and Drug Administration said in a news release.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.